Pliant Therapeutics to Participate in Needham Healthcare Conference
SOUTH SAN FRANCISCO, Calif., April 05, 2022 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX),…
Month: April 2022
CLS Holdings USA, Inc to Host Q3, 2022 Financial Results on April 14, 2022
LAS VEGAS, April 05, 2022 (GLOBE NEWSWIRE) — CLS Holdings USA, Inc. (OTCQB:CLSH) (CSE:CLSH), the…
Collegium Provides 2022 Financial Guidance
– Total Product Revenues Expected in the Range of $450.0 million to $465.0 million –…
Mersana Therapeutics to Present Preclinical Data on XMT-1660, XMT-2056 and the Immunosynthen Platform at AACR Annual Meeting
XMT-1660 demonstrates robust activity in preclinical models of breast cancer XMT-2056 demonstrates robust activity as…
Humacyte Expands Leadership Team with Appointment of Shamik Parikh, M.D., as Chief Medical Officer
–Seasoned physician, scientist and life science executive brings expertise in clinical research and development across…
Achilles Therapeutics to Present at Upcoming Conferences
LONDON, April 05, 2022 (GLOBE NEWSWIRE) — Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical…
Sunshine Biopharma’s Newly Designed mRNA Molecules Prove Effective Against Multidrug Resistant Cancer Cells
A Potential Multi-Billion Dollar Global Market Opportunity for Cancer Treatments MONTREAL, April 05, 2022 (GLOBE…
Cullinan Oncology to Participate in Upcoming Virtual Healthcare Conferences
CAMBRIDGE, Mass., April 05, 2022 (GLOBE NEWSWIRE) — Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan”) a…
NextCure to Present at 21st Annual Needham Virtual Healthcare Conference
BELTSVILLE, Md., April 05, 2022 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical…
MBX Biosciences Appoints Ora Hirsch Pescovitz, M.D., to Board of Directors
CARMEL, Ind., April 05, 2022 (GLOBE NEWSWIRE) — MBX Biosciences, Inc., a clinical stage biopharmaceutical…
PepGen Appoints Michelle Mellion, M.D., as Senior Vice President, Head of Clinical Development
Dr. Mellion brings deep experience in neuromuscular disease research and treatment as a biopharma executive,…
Kane Biotech Appoints Dr. Gregory Schultz as Chief Scientific Officer
WINNIPEG, Manitoba, April 05, 2022 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the…
Chinook Therapeutics, IgA Nephropathy Foundation and Komodo Health Collaborate to Provide Nephrologists with Support and Information to Help Reduce Barriers to Diagnosis and Care
SEATTLE, April 05, 2022 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (Nasdaq: KDNY), the IgA Nephropathy…
Longeveron Expands Executive Leadership Team; Appoints K. Chris Min, M.D., Ph.D. as Chief Medical Officer
Dr. Min will lead global clinical development and regulatory strategy MIAMI, April 05, 2022 (GLOBE…
OpGen Announces Interim Analysis Results from Clinical Trial for Unyvero Urinary Tract Infection Panel
Interim analysis performed with initial 150 U.S. patient samples enrolled in its prospective multicenter trial…
Radius Provides Agenda for Today’s R&D Webcast
Focus: RAD011, an investigational synthetic cannabidiol oral solution Webcast details: 10:00am to 12:00pm for current…
Generation Bio to Participate in 21st Annual Needham Virtual Healthcare Conference
CAMBRIDGE, Mass., April 05, 2022 (GLOBE NEWSWIRE) — Generation Bio Co. (Nasdaq: GBIO), a biotechnology…
Avicanna Expands its Derma-Cosmetics Brand Pura H&W™ into the European Union through a Partnership with Bio-Gate AG
Brand Pura H&W™ Brand Pura H&W™ The exclusive distribution agreement includes 5 SKUs from Pura…
Verrica Pharmaceuticals Announces First Patient Dosed in Phase 2 Study of LTX-315, a Potential First-in-Class Oncolytic Peptide-Based Immunotherapy, for the Treatment of Basal Cell Carcinoma
LTX-315’s novel mechanism of action directly targets cancerous skin cells to induce an anti-tumor immune…
Mindset Pharma to Participate in Upcoming Conferences in April 2022
TORONTO, April 05, 2022 (GLOBE NEWSWIRE) — Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB:…